PureK Holdings Corp. ‘TRUBAR’ Plant-Based Nutrition Brand to Expand Into Canada
VANCOUVER, British Columbia, March 25, 2021 (GLOBE NEWSWIRE) -- PureK Holdings Corp. (the "Company" or "PureK") (TSX Venture: PKAN) is...
News
Solid Biosciences to Participate at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Day
CAMBRIDGE, Mass., March 25, 2021 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing...
Abeona Therapeutics Announces Appointment of Two New Independent Members to its Board of Directors
Refreshed board to bring fresh perspectives, relevant expertise and diverse experienceNEW YORK and CLEVELAND, March 25, 2021 (GLOBE NEWSWIRE) --...
Avicanna to Participate in Benzinga Biotech Small Cap Conference and the Virtual Life Sciences Investor Forum Both Taking Place on Thursday March 25th
TORONTO, March 25, 2021 (GLOBE NEWSWIRE) -- Avicanna Inc. ("Avicanna" or the "Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a...
Venus Concept Announces Global Brand Ambassador Partnership with Tennis Champion and Entrepreneur Venus Williams
TORONTO, March 25, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical...
Otonomy Initiates Phase 2 Clinical Trial of OTO-313 in Tinnitus
Phase 2 study design based on successful Phase 1/2 trial including use of Tinnitus Functional Index (TFI) responder analysis for...
Aurora Spine Receives FDA 510(K) Clearance for Its Proprietary APOLLO Anterior Cervical Plate
CARLSBAD, Calif., March 25, 2021 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF),...
Orpea SA: Pre Stabilisation Notice
PARIS, March 25, 2021 (GLOBE NEWSWIRE) -- ORPEA SA Pre Stabilisation Notice HSBC (contact: 'synd manager'; telephone: +44 207 992...
Aleafia Health Reports 2020 Year End Results, Record Quarterly Revenue
233% increase in Q/Q cannabis net revenue$4.3 million positive adjusted EBITDA in Q4 202042% and 501% increase in Q/Q medical...
Zentalis Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Update
Initiated multiple early-stage clinical trials evaluating its oral SERD, ZN-c5, WEE1 inhibitor, ZN-c3 and BCL-2 inhibitor, ZN-d5 Announced strategic collaboration...
Immunocore Provides Business Update and Reports Full Year 2020 Financial Results
Immunocore Provides Business Update and Reports Full Year 2020 Financial Results Breakthrough Therapy Designation granted by the FDA for tebentafusp...
VBL Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
Conference Call and Webcast at 8:30 a.m. EDT Today Continued progress in OVAL Phase 3 registration enabling study investigating VB-111...
Sanford Health partners with Congenica to provide answers for undiagnosed rare disease patients
Sanford Health partners with Congenica to provide answers for undiagnosed rare disease patients Multi-year study will use Congenica’s platform for...
Passage Bio to Participate in Upcoming April Investor Conferences
PHILADELPHIA, March 25, 2021 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a genetic medicines company focused on developing transformative...
AGTC Announces New Initiatives To Enhance The Patient Journey In Its XLRP Trials
-AGTC’s deep commitment to the patient voice drives solutions to support patient access to information and to improve the experience...
Medicenna Announces Preclinical Data on MDNA11 with Anti-PD-1 Therapy and Unveils Novel Bifunctional Superkines at the Cytokine-Based Cancer Immunotherapies Summit
-- MDNA11 and anti-PD-1 combination leads to complete responses in a murine solid tumor model -- Preclinical data demonstrates the...
MatriSys Bioscience Names Joyce Rico as Chief Medical Officer
LA JOLLA, Calif., March 25, 2021 (GLOBE NEWSWIRE) -- MatriSys Bioscience, a company harnessing beneficial bacteria to treat inflammatory skin...
G1 Therapeutics’ COSELA™ (trilaciclib) Included in Two Updated National Comprehensive Cancer Network® (NCCN) Clinical Practice Guidelines in Oncology
COSELA Added to Both the NCCN Treatment Guidelines for Small Cell Lung Cancer and the NCCN Supportive Care Guidelines for...
Annexon Biosciences Reports Fourth Quarter and Full-Year 2020 Financial Results with Recent Business Highlights
SOUTH SAN FRANCISCO, Calif., March 25, 2021 (GLOBE NEWSWIRE) -- Today Annexon, Inc. (“Annexon”) (Nasdaq: ANNX), a clinical-stage biopharmaceutical company...
InflaRx Reports Full Year 2020 Financial & Operating Results
Submitted a Special Protocol Assessment to the FDA for Phase III program evaluating vilobelimab in Hidradenitis Suppurativa (HS) in Q1...